SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Celldex Therapeutics, Inc. – ‘10-Q’ for 6/30/22 – ‘XML’

On:  Monday, 8/8/22, at 4:06pm ET   ·   For:  6/30/22   ·   Accession #:  1104659-22-87222   ·   File #:  0-15006

Previous ‘10-Q’:  ‘10-Q’ on 5/5/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/9/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 11/2/23 for 9/30/23   ·   4 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/08/22  Celldex Therapeutics, Inc.        10-Q        6/30/22   60:5.5M                                   Toppan Merrill/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.26M 
 2: EX-10.3     Material Contract                                   HTML     29K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
11: R1          Document and Entity Information                     HTML     73K 
12: R2          Condensed Consolidated Balance Sheets               HTML    113K 
13: R3          Condensed Consolidated Balance Sheets               HTML     35K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     86K 
                and Comprehensive Loss                                           
15: R5          Condensed Consolidated Statements of Cash Flow      HTML     80K 
16: R6          Basis of Presentation                               HTML     25K 
17: R7          Significant Accounting Policies                     HTML     21K 
18: R8          Fair Value Measurements                             HTML     96K 
19: R9          Marketable Securities                               HTML    110K 
20: R10         Intangible Assets                                   HTML     20K 
21: R11         Other Long-Term Liabilities                         HTML     36K 
22: R12         Stockholders' Equity                                HTML    153K 
23: R13         Stock-Based Compensation                            HTML     81K 
24: R14         Accumulated Other Comprehensive Income              HTML     40K 
25: R15         Revenue                                             HTML     23K 
26: R16         Income Taxes                                        HTML     22K 
27: R17         Net Loss Per Share                                  HTML     27K 
28: R18         Kolltan Acquisition                                 HTML     28K 
29: R19         Significant Accounting Policies (Policies)          HTML     20K 
30: R20         Fair Value Measurements (Tables)                    HTML     95K 
31: R21         Marketable Securities (Tables)                      HTML    108K 
32: R22         Other Long-Term Liabilities (Tables)                HTML     35K 
33: R23         Stockholders' Equity (Tables)                       HTML    148K 
34: R24         Stock-Based Compensation (Tables)                   HTML     84K 
35: R25         Accumulated Other Comprehensive Income (Tables)     HTML     39K 
36: R26         Net Loss Per Share (Tables)                         HTML     26K 
37: R27         Basis of Presentation (Details)                     HTML     30K 
38: R28         Fair Value Measurements (Details)                   HTML     45K 
39: R29         Fair Value Measurements - Contingent Consideration  HTML     26K 
                Liabilities (Details)                                            
40: R30         Fair Value Measurements - Additional information    HTML     29K 
                (Details)                                                        
41: R31         Marketable Securities (Details)                     HTML     58K 
42: R32         Marketable Securities - Additional Information      HTML     21K 
                (Details)                                                        
43: R33         Intangible Assets (Details)                         HTML     19K 
44: R34         Other Long-Term Liabilities (Details)               HTML     32K 
45: R35         Other Long-Term Liabilities- New Jersey tax         HTML     26K 
                benefits (Details)                                               
46: R36         Stockholders' Equity (Details)                      HTML     60K 
47: R37         Stock-Based Compensation - Stock Option Activity    HTML     64K 
                (Details)                                                        
48: R38         Stock-Based Compensation - Employee Stock Option    HTML     29K 
                and Incentive Plan Activity Additional Information               
                (Details)                                                        
49: R39         Stock-Based Compensation - Expenses (Details)       HTML     24K 
50: R40         Stock-Based Compensation - Valuation (Details)      HTML     32K 
51: R41         Accumulated Other Comprehensive Income (Details)    HTML     38K 
52: R42         Revenue (Details)                                   HTML     38K 
53: R43         Income Taxes (Details)                              HTML     19K 
54: R44         Net Loss Per Share (Details)                        HTML     22K 
55: R45         Kolltan Acquisition (Details)                       HTML     39K 
58: XML         IDEA XML File -- Filing Summary                      XML    103K 
56: XML         XBRL Instance -- cldx-20220630x10q_htm               XML   1.45M 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX     82K 
 7: EX-101.CAL  XBRL Calculations -- cldx-20220630_cal               XML    114K 
 8: EX-101.DEF  XBRL Definitions -- cldx-20220630_def                XML    327K 
 9: EX-101.LAB  XBRL Labels -- cldx-20220630_lab                     XML    756K 
10: EX-101.PRE  XBRL Presentations -- cldx-20220630_pre              XML    529K 
 6: EX-101.SCH  XBRL Schema -- cldx-20220630                         XSD     94K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              248±   387K 
60: ZIP         XBRL Zipped Folder -- 0001104659-22-087222-xbrl      Zip    221K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.22.2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 111 </ContextCount>
<ElementCount> 199 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 25 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 4 </UnitCount>
<MyReports>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00090 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets </Role>
<ShortName> CONDENSED CONSOLIDATED BALANCE SHEETS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss </Role>
<ShortName> CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlow </Role>
<ShortName> CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 10101 - Disclosure - Basis of Presentation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentation </Role>
<ShortName> Basis of Presentation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 10201 - Disclosure - Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPolicies </Role>
<ShortName> Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 10301 - Disclosure - Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements </Role>
<ShortName> Fair Value Measurements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 10401 - Disclosure - Marketable Securities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities </Role>
<ShortName> Marketable Securities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 10501 - Disclosure - Intangible Assets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureIntangibleAssets </Role>
<ShortName> Intangible Assets </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 10601 - Disclosure - Other Long-Term Liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities </Role>
<ShortName> Other Long-Term Liabilities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 10701 - Disclosure - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity </Role>
<ShortName> Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 10801 - Disclosure - Stock-Based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation </Role>
<ShortName> Stock-Based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 10901 - Disclosure - Accumulated Other Comprehensive Income </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncome </Role>
<ShortName> Accumulated Other Comprehensive Income </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 11001 - Disclosure - Revenue </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureRevenue </Role>
<ShortName> Revenue </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 11101 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 11201 - Disclosure - Net Loss Per Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare </Role>
<ShortName> Net Loss Per Share </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 11301 - Disclosure - Kolltan Acquisition </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisition </Role>
<ShortName> Kolltan Acquisition </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 20202 - Disclosure - Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesPolicies </Role>
<ShortName> Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPolicies </ParentRole>
<Position> 19 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 30303 - Disclosure - Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables </Role>
<ShortName> Fair Value Measurements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements </ParentRole>
<Position> 20 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 30403 - Disclosure - Marketable Securities (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables </Role>
<ShortName> Marketable Securities (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 30603 - Disclosure - Other Long-Term Liabilities (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables </Role>
<ShortName> Other Long-Term Liabilities (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 30703 - Disclosure - Stockholders' Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityTables </Role>
<ShortName> Stockholders' Equity (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 30803 - Disclosure - Stock-Based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationTables </Role>
<ShortName> Stock-Based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 30903 - Disclosure - Accumulated Other Comprehensive Income (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeTables </Role>
<ShortName> Accumulated Other Comprehensive Income (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncome </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 31203 - Disclosure - Net Loss Per Share (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareTables </Role>
<ShortName> Net Loss Per Share (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 40101 - Disclosure - Basis of Presentation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentationDetails </Role>
<ShortName> Basis of Presentation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentation </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 40301 - Disclosure - Fair Value Measurements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails </Role>
<ShortName> Fair Value Measurements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 40302 - Disclosure - Fair Value Measurements - Contingent Consideration Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsContingentConsiderationLiabilitiesDetails </Role>
<ShortName> Fair Value Measurements - Contingent Consideration Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 40303 - Disclosure - Fair Value Measurements - Additional information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails </Role>
<ShortName> Fair Value Measurements - Additional information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 30 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 40401 - Disclosure - Marketable Securities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails </Role>
<ShortName> Marketable Securities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 40402 - Disclosure - Marketable Securities - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesAdditionalInformationDetails </Role>
<ShortName> Marketable Securities - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 32 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 40501 - Disclosure - Intangible Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsDetails </Role>
<ShortName> Intangible Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureIntangibleAssets </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 40601 - Disclosure - Other Long-Term Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails </Role>
<ShortName> Other Long-Term Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 40602 - Disclosure - Other Long-Term Liabilities- New Jersey tax benefits (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesNewJerseyTaxBenefitsDetails </Role>
<ShortName> Other Long-Term Liabilities- New Jersey tax benefits (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 35 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 40701 - Disclosure - Stockholders' Equity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails </Role>
<ShortName> Stockholders' Equity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityTables </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 40801 - Disclosure - Stock-Based Compensation - Stock Option Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationStockOptionActivityDetails </Role>
<ShortName> Stock-Based Compensation - Stock Option Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 37 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 40802 - Disclosure - Stock-Based Compensation - Employee Stock Option and Incentive Plan Activity Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationEmployeeStockOptionAndIncentivePlanActivityAdditionalInformationDetails </Role>
<ShortName> Stock-Based Compensation - Employee Stock Option and Incentive Plan Activity Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 38 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 40803 - Disclosure - Stock-Based Compensation - Expenses (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationExpensesDetails </Role>
<ShortName> Stock-Based Compensation - Expenses (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 39 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 40804 - Disclosure - Stock-Based Compensation - Valuation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationValuationDetails </Role>
<ShortName> Stock-Based Compensation - Valuation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 40 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 40901 - Disclosure - Accumulated Other Comprehensive Income (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeDetails </Role>
<ShortName> Accumulated Other Comprehensive Income (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeTables </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 41001 - Disclosure - Revenue (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureRevenueDetails </Role>
<ShortName> Revenue (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureRevenue </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 41101 - Disclosure - Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails </Role>
<ShortName> Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes </ParentRole>
<Position> 43 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 41201 - Disclosure - Net Loss Per Share (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails </Role>
<ShortName> Net Loss Per Share (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareTables </ParentRole>
<Position> 44 </Position>
</Report>
<Report instance="cldx-20220630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 41301 - Disclosure - Kolltan Acquisition (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionDetails </Role>
<ShortName> Kolltan Acquisition (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisition </ParentRole>
<Position> 45 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-Q" original="cldx-20220630x10q.htm"> cldx-20220630x10q.htm </File>
<File> cldx-20220630.xsd </File>
<File> cldx-20220630_cal.xml </File>
<File> cldx-20220630_def.xml </File>
<File> cldx-20220630_lab.xml </File>
<File> cldx-20220630_pre.xml </File>
<File> cldx-20220630xex10d3.htm </File>
<File> cldx-20220630xex31d1.htm </File>
<File> cldx-20220630xex31d2.htm </File>
<File> cldx-20220630xex32d1.htm </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy items="456"> http://fasb.org/us-gaap/2022 </BaseTaxonomy>
<BaseTaxonomy items="31"> http://xbrl.sec.gov/dei/2022 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/24  Celldex Therapeutics, Inc.        10-K       12/31/23   87:8.5M                                   Toppan Merrill/FA2
 2/28/23  Celldex Therapeutics, Inc.        10-K       12/31/22   85:8.1M                                   Toppan Merrill/FA

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/18/22  Celldex Therapeutics, Inc.        8-K:1,9     7/15/22   11:257K                                   Toppan Merrill/FA
 6/23/22  Celldex Therapeutics, Inc.        8-K:1,2,9   6/20/22   11:225K                                   Toppan Merrill/FA
↑Top
Filing Submission 0001104659-22-087222   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 1:24:59.1am ET